EDWARDS LIFESCIENCES CORP (EW)
US28176E1082 - Common Stock
ChartMill assigns a Buy % Consensus number of 74% to EW. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 98.09. This target is 12.89% above the current price.
EW was analyzed by 40 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about EW.
In the previous month the buy percentage consensus was at a similar level.
EW was analyzed by 40 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-30 | Goldman Sachs | Initiate | Buy |
| 2024-05-22 | Citigroup | Upgrade | Neutral -> Buy |
| 2024-05-14 | Deutsche Bank | Upgrade | Hold -> Buy |
| 2024-05-07 | Barclays | Maintains | Overweight -> Overweight |
| 2024-04-26 | Stifel | Maintains | Hold -> Hold |
| 2024-04-26 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-04-26 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-04-26 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-04-15 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-04-11 | Mizuho | Maintains | Buy -> Buy |
| 2024-04-04 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-04-03 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-03-26 | OTR Global | Upgrade | Mixed -> Positive |
| 2024-03-21 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-03-18 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-07 | B of A Securities | Upgrade | Neutral -> Buy |
| 2024-02-07 | Mizuho | Maintains | Buy -> Buy |
| 2024-02-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-07 | Stifel | Maintains | Hold -> Hold |
| 2024-02-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-02-02 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-01-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-01-04 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2023-12-22 | Truist Securities | Maintains | Buy -> Buy |
| 2023-12-11 | Truist Securities | Maintains | Buy -> Buy |
| 2023-12-11 | Citigroup | Downgrade | Buy -> Neutral |
| 2023-12-04 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-11-28 | Wolfe Research | Downgrade | Peer Perform -> Underperform |
| 2023-10-26 | Mizuho | Maintains | Buy -> Buy |
| 2023-10-26 | RBC Capital | Maintains | Outperform -> Outperform |